So with increasing case's of Covid-19 in Japan.
Why is Fuji Film wasting their time.
https://www.clinicaltrialsarena.com/special-focus/covid-19/globaldata-epidemiologist-report-global-covid-19-cases-pass-20-95-million-japan-second-wave-more-severe-than-first/While this article is some 5 week's old.
TOKYO (Reuters) -- A clinical trial of Fujifilm Holdings Corp's Avigan drug yielded inconclusive results as a treatment of COVID-19, Japanese researchers said on Friday.
Although patients given the drug early in the trial showed more improvement than those who got delayed doses, the results did not reach statistical significance, Fujita Health University researcher Yohei Doi said.
The results, announced at a news conference on Friday, followed the completion of a clinical trial conducted between March and May on 89 patients across Japan.
Japanese Prime Minister Shinzo Abe had said he hoped the drug would be approved as a COVID-19 treatment in May, but a shortage of patients in Japan delayed the progress of clinical trials. It has been approved as a COVID-19 treatment in Russia and India.
https://asia.nikkei.com/Business/Pharmaceuticals/Fujifilm-s-Avigan-inconclusive-as-COVID-19-treatment-in-Japan-trialThen this article some 11 week's old.
TOKYO -- Propelled by the wave of keen interest in promising treatments for the coronavirus, Fujifilm Holdings is ready to shed its image as a camera film and copier maker and become known as an operation centered on health care.
The company announces its results for the year ended March on Friday. Market watchers are particularly interested in any comments regarding the flu drug Avigan, one of the most-talked-about candidates to treat COVID-19."We are at the point where health tech, not office documents, becomes the primary factor for Fujifilm's valuation," said analyst Masahiro Ono of Morgan Stanley MUFG Securities.
The Japanese government aims to approve Avigan as a COVID-19 treatment by the end of May, despite birth defects as a potential side effect and recent reports casting doubt on its effectiveness against the new coronavirus. Fujifilm is expected to file an application soon.
https://asia.nikkei.com/Business/Companies/Fujifilm-pictures-new-pharma-heavy-identity-with-AviganIf I was the head of Fuji Film, I would pick the phone and ring Dr Ross McDonald and say, let start the trial's for Covid-19 using C.Y.P. cell's immediately, in Japan.
IMHO.
Regards
Rossi70
(20min delay)